Chemours Co
XETRA:2CU
Chemours Co
XETRA:2CU
Price:
18.13
EUR
Market Closed
Market Cap:
€3B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
C
|
Chemours Co
XETRA:2CU
|
US |
|
U
|
United Therapeutics Corp
F:UTH
|
US |
|
P
|
Pexip Holding ASA
XBER:4W9
|
NO |
|
Opthea Ltd
ASX:OPT
|
AU |
|
Ipsen SA
PAR:IPN
|
FR |
|
BAE Systems PLC
OTC:BAESY
|
UK |
Wall St Price Targets
2CU Price Targets Summary
Chemours Co
Chemours Co
Wall Street analysts forecast 2CU stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for 2CU is 22.43 EUR with a low forecast of 17.35 EUR and a high forecast of 25.77 EUR.
Lowest Forecast
Price Target
17.35
EUR
4% Downside
Average Forecast
Price Target
22.43
EUR
24% Upside
Highest Forecast
Price Target
25.77
EUR
42% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 2CU's stock price target?
Price Target
22.43
EUR
22.43
EUR
According to Wall Street analysts, the average 1-year price target for 2CU is 22.43 EUR with a low forecast of 17.35 EUR and a high forecast of 25.77 EUR.
What is the Revenue forecast for Chemours Co?
Projected CAGR
6%
6%
Over the last 13 years, the compound annual growth rate for Revenue has been -2%. The projected CAGR for the next 3 years is 6%.
